’s Post Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. Volver. D. … | 79 comments on LinkedInRami Hannoush, Ph. D. 19th Ave New York, NY 95822, USA. Recent work has focused. BSMB Spring meeting 2022: "Interactions between Lipids/derivatives and the ECM: pre-clinical and clinical relevance" Registration for BSMB members is FREE, £10 and £30 respectively for student. EpiBiologics's CEO is Rami Hannoush What does EpiBiologics do? Founded in 2022, EpiBiologics is a biotechnology company with a focus on antibody-based protein degradation. D. D. D. Additional Details: 1000 Ask Question Find a Lawyer. Dr. D General Information. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. 1038/nchembio. ’s Post Rami Hannoush, Ph. It’s been a terrific two days at #jpm2023, meeting new talent and connecting with friends in pharma and the VC world. ’s Post Rami Hannoush, Ph. Wnt ligands are critical for tissue homeostasis and form a complex with LRP6 and frizzled coreceptors to initiate Wnt/β-catenin signaling. The seven-transmembrane-spanning receptors of the FZD 1–10 class are bound and activated by the WNT family of lipoglycoproteins, thereby inducing a complex network of signaling pathways. Mubadala Capital Ventures General Partner Sep 2021. Clickable fatty acids coupled with in situ proximity ligation allow visualization of Wnt as it trafficks through the secretory pathway, defining roles for palmitoylation and glycosylation in. This button displays the currently selected search [email protected] Hannoush, Ph. Rami Hannoush’s Post. Back. Rami Hannoush, education was also an escape. Thank you Susquehanna University and the…Surrey fellows of the future fellowships: post-doctoral fellowships opportunities leading to a tenured academic position after three years. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. , USA) "Challenges and Emerging Approaches in Peptide Drug Discovery" 9:25 am - 9:40 am: Discussion. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami. D. 1038/s41589-018-0035-2 Abstract Regeneration of the adult intestinal epithelium is mediated by a pool of cycling stem cells, which are located at the base of the crypt, that express leucine-rich-repeat-containing. D. THE AURON TEAM A CULTURE OF INNOVATION. Expand search. Supplementary Figure 1 S5 . Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. D. D. ’s Post Rami Hannoush, Ph. D. Mr. Healthcare VC | Life sciences company creation 1yRami Hawash is the owner of a car mechanical repair business in Romford, Essex. D. Back [email protected] last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Tracking Wnts throughout such processes will present a challenge, but might be facilitated by emerging techniques, such as a method for metabolic labeling of palmitoylated Wnts presented by Rami Hannoush (Genentech, San Francisco, USA) . rami@gene. Rami Hannoush, Ph. Rami Hannoush, PhD. D. He most recently served as a general partner at Mubadala Capital, building the firm's healthcare platform in the. He focuses on early. View the profiles of professionals named "Rami D" on LinkedIn. The authors declare no competing financial interests. Epub 2021 Dec 10. … | 79 comments on LinkedInRami Hannoush, Ph. ’s Post Rami Hannoush, Ph. “Dysregulation of normal cellular differentiation processes can alter normal cell biology leading to tumor formation and progression,” said Dr. D. Simon Hansen 1 , Yingnan Zhang 1 , Sunhee Hwang 1 , Ahmad Nabhan 2 , Wanqing Li 1 , Jakob Fuhrmann 1 , Yvonne Kschonsak 3 , Lijuan Zhou 1 , Aaron H Nile 1 , Xinxin Gao 1 , Robert Piskol 3 , Felipe de Sousa E Melo 3 , Frederic J de Sauvage 3 , Rami N Hannoush 1 Contact Rami directly. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Back. I am a Scientist in the Physiological Chemistry Department of Genentech's research organization. The Hedgehog and Wnt signaling pathways in cancer. ’s Post Rami Hannoush, Ph. This button displays the currently selected search type. Speakers – APS 2022. Edit Recent News and Activity Section. Marianne Mertens, Ph. Connect Hamed Alemohammad Greater Boston. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. D. com). When expanded it provides a list of search options that will switch the search inputs to match the. EpiBiologics’s CEO is Rami Hannoush Who are EpiBiologics key employees? Some of EpiBiologics key employees are Craig Lichtenstein Where is EpiBiologics located? EpiBiologics’s headquarters are located at 1900 Alameda De Las Pulgas Ste 250, San Mateo, California, 94403, United States How do I contact. 11mo Report this comment Report Report. Corresponding author. com. 11mo Report this comment Report Report. Hannoush is a general partner at Mubadala Capital, the financial investment arm of the Sovereign Wealth Fund Mubadala. D. Rami Hannoush, Ph. Skip to main content Due to a planned power outage on Friday, 1/14, between 8am. Manage my profile. S. Wnt ligands are critical for tissue homeostasis and form a complex with LRP6 and frizzled coreceptors to initiate Wnt/β-catenin signaling. ’s Post Rami Hannoush, Ph. Rami N. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 5mo Report this post Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. On average, Rami Hannoush works for one company for 2 years 7 months. ’s Post Rami Hannoush, Ph. Symposium Sponsors. D. Rami Hannoush, Ph. Welcome, Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. rami@gene. Rami Hannoush, PhDPrincipal Scientist & Group Leader at Genentech. Lawyers - Get Listed Now! Get a free. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 3h Report this post. Last updated 6 months ago. D. The design of clickable fatty acid probes is based on the introduction of a small chemical tag (alkyne or azide) at the ω or methyl end of the fatty acid (Figure 2). Genentech veteran Rami Hannoush, UCSF professor Jim Wells team up to score $50M for protein degradation startup EpiBiologics - San Francisco Business TimesThere are 8 professionals named "Rami D", who use LinkedIn to exchange information, ideas, and opportunities. Expand search. There are 3 professionals named "Rami Hannoush", who use LinkedIn to exchange information, ideas, and opportunities. Hannoush, Rami Nabil; Contributors. D. D. Lawyers - Get Listed Now! Get a free. D. The small size of the chemical tag is meant to minimize interference with fatty acyltransferase substrate recognition and catalytic efficiency (Hannoush, 2015, Hannoush and Arenas. Fatty acylation of proteins is a versatile co-translational or post-translational modification that plays a key role in human. D. ’s Post Rami Hannoush, Ph. Company Type For Profit. Rami Hannoush, Ph. D. 1038/nchembio. D. Rami Hannoush, Genentech, South San Francisco, USA 5:25 pm General Discussion, Day 2 Wrap-Up 6:00 pm Reception, dinner . interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. Rami Hannoush, Dr. ’s Post Rami Hannoush, Ph. Targeting the destruction of proteins, Peninsula biotech EpiBiologics raises $50M. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. com. PMID: 24292069. 1016/j. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. She is taking over from co-founder Rami Hannoush, who will step into an advisory role. Rami Hannoush 7mo Report this post 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of patients with unmet medical needs and protect. PMID: 26080277 DOI: 10. The 2020 program will feature invited talks from academic. Connect Lana Janes, Ph. D. A fascinating approach to degrade membrane proteins/receptors. He also recently joined Versant Ventures (as a venture partner) where he. Scroll Top. D. Rami Hannoush has been working as a General Partner | US Ventures for Mubadala for 456 days. Developing tool ligands that target individual LRP6 domains could help elucidate the mechanism of. … | 79 comments on LinkedInRami Hannoush, Ph. D. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. ’s Post Rami Hannoush, Ph. D. When expanded it provides a list of search options that will switch the search inputs to match the. EpiBiologics - a biotechnology company advancing a next-generation antibody-based protein degradation platform and pipeline for membrane and extracellular drug targets - recently announced the company brought the total series A round to $73 million with the addition of $23 million from new investors Digitalis Ventures, Taiho Ventures, and existing investor Codon Capital. The author has contributed to research in topics: Wnt signaling pathway & Frizzled. D. ’s Post Rami Hannoush, Ph. EpiBiologics Executive Team & Key Decision Makers. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1y 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of. Rami Hannoush, Ph. Hannoush and Arenas-Ramirez, 2009; Martin and Cravatt, 2009) also showed efficient bioorthogonal labeling of fatty acyl-Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami Hannoush was treated to a caffeine-fueled review of the latest work UCSF’s Jim Wells had been doing on protein degradation — one of the hottest fields in drug development. Healthcare VC | Life sciences company creation 6 TageThank you Ayman, Alaa, and Rami for your trust and support! Could not have asked for better partners. One of the toughest things about handing off your bookkeeping is figuring out what to do with all your extra time. 025 Abstract Fatty acylation of proteins is a versatile co-translational or post-translational modification that plays a key role in human physiology and disease. Hannoush. Related to: Rana Hannoush, 42. Rami N. , South San Francisco, CA, USA. hannoush. Recommended articles. D. Jumi Shin, University of Toronto. ” Prior to EpiBiologics, Dr. D. D. Less time bookkeeping means more time to pursue your. The . Rami Hannoush, Ph. Leading strategies for expediting R&D and improving CMC efficiency. Drug Discovery & Development Oncology Wnt and Stem Cells Peptide Therapeutics. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. com. Join to view full profile. Rami Hannoush has 2 current jobs as General Partner at Mubadala Capital Ventures and Co-Founder at EpiBiologics. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1y EditedRami Hannoush, Ph. ’s Post Rami Hannoush, Ph. Rami Hannoush, Ph. Both structures reveal a dimeric arrangement of the CRD. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. Search for more papers by this author Speakers – APS 2022. Electronic address: hannoush. Expand search. A phone number associated with this person is (617) 576-7262 in the local area code 617. D. Rami Hannoush, Ph. D. Human OS cell lines (MNNG/HOS, MG-63, and U2-OS) were treated with increasing concentrations of dynasore or cisplatin, and then the cell. English. Mar 22, 2023. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Based on the protocol by Xinxin Gao and Rami N. com. Inventors: Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark Solloway, Yan Wu METHODS AND COMPOSITIONS FOR MODULATING THE Wnt PATHWAY Protein palmitoylation plays diverse roles in regulating the trafficking, stability, and activity of cellular proteins. Read top stories published by MubadalaVentures. Citizen and Immigration Services 2019 Outstanding Americans by. Competing interests. Question: Add details. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 4mo Report this post Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. Founded in 2022 and led by CEO Dr. . Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 5mo Report this post In an interview with BioPharma Dive. D. Back. 1073/pnas. D. Hannoush, 5Wayne J. Burns, Irina Krylova, Rami N. ’s Post Rami Hannoush, Ph. Corresponding author. ’s Post Rami Hannoush, Ph. Rami Hannoush, Ph. Rami Hannoush. The authors would like to acknowledge Dr. D. Congratulations to our own Rami Hannoush, Principal Scientist, Early Discovery Biochemistry, for being one of ten to receive the U. ’s Post Rami Hannoush, Ph. Rami Hannoush General Partner, Mubadala Capital | Life sciences company creation | Chief Scientific Officer 10mo EditedUSA. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. Hannoush is a general partner at Mubadala Capital, the financial investment arm of the Sovereign Wealth Fund Mubadala. Owing to a lack of robust detection technologies, the mechanisms by. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. D. Sponsors and Exhibitors. Rami Hannoush is a venture partner operating across San Diego and the San Francisco Bay Area. degree at McGill University. Rami Hannoush, Ph. Shawn Zhang Karthik Nagapudi Mike Shen Joshua Lomeo Yuri Qin Aiden Zhu Purnendu Nayak Debby Chang Rami N Hannoush. Rami Hannoush is the co-founder, interim CEO and president of EpiBiologics. EpiBiologics develops antibody-based targeted therapies against. I had the pleasure to join Rob Faulkner and Soo Romanoff on a. This is a mechanism that's been conserved throughout the animal kingdom,” explains Rami Hannoush, interim CEO and co-founder of EpiBiologics. The Frizzled (FZD) 7 receptor (FZD7) is enriched in LGR5 + intestinal stem cells and plays a critical role in their self-renewal. Inventors: Stefan Dengl, Rami Hannoush, Simon Theodor Hansen, Peter Michael Huelsmann, Robert Franklin Kelley, Hubert Kettenberger, Shrenik Chetan Mehta, Devin Brent Tesar HYALURONIC ACID BINDING DERIVATIVES OF VERSICAN (VG1) FOR LONG ACTING DELIVERY OF THERAPEUTICSRead all stories published by MubadalaVentures in 2022. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 4mo Edited Report this post At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it provides a blueprint that. Seminar Title: Challenging Targets and Emerging Approaches for Cellular Imaging in the Wnt Pathway, powered by Localist Event Calendar SoftwareRami Hannoush, Ph. 5 From the Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden, the Faculty of Science, Institute of Experimental. D. D. Specific lab interests include Wnt signaling, protein. ’s Post Rami Hannoush, Ph. D. D. Rami Hannoush, Ph. Biomarker interview with Rami Hannoush, Ph. On average, Rami Hannoush works for one company for 2 years 7 months. Electronic address: hannoush. English. Genentech, McGill, Harvard, Versant Ventures. D. Aaron H Nile & Rami N Hannoush* Wnt proteins are critical regulators of signaling networks during embryonic development and in adult tissue homeostasis. Jennifer Stockdill, Wayne State. Hannoush include Harvard University & Scripps Research Institute. Eric Shiozaki: Casdin Capital — BrightEdge Fund — Arkin Bio Ventures — Apollo Health Ventures . Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. ’s Post Rami Hannoush, Ph. I am thankful for the LPs, founders, CEOs, team members who have remained steadfast partners over the years in using advanced technology to build a better… | 13 comments on LinkedInRami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Rami N Hannoush Adjunct Professor, Chemical and Systems Biology Operations Print Profile Email Profile Bio Bio Professional Contact. This button displays the currently selected search type. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Background. 2014. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. He brings a unique blend of investment experience and deep drug discovery expertise to our company. EpiBiologics’s CEO is Rami Hannoush Who are EpiBiologics key employees? Some of EpiBiologics key employees are Craig Lichtenstein Where is EpiBiologics located? EpiBiologics’s headquarters are located at 1900 Alameda De Las Pulgas Ste 250, San Mateo, California, 94403, United States How do I contact EpiBiologics? Rami Hannoush, Ph. Rami N. Rami N. Back. Aaron H Nile 1 , Susmith Mukund 2 , Karen Stanger 1 , Weiru Wang 2 , Rami N Hannoush 3 Affiliations 1 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94080. The Wnt Signaling GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. Back. When expanded it provides a list of search options that will switch the search inputs to match the. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation 6dTherapeutics. We also report a crystal structure of human FZD5 CRD bound to C16:1 cis -Δ9 unsaturated fatty acid. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1y Report this post Report Report. ’s Post Rami Hannoush, Ph. Alanna Schepartz, The University of California, Berkeley. Rami Hannoush, Ph. 3 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94080; hannoush. D. D. Expand search. EpiBiologics is building a next-generation antibody-based protein degradation platform for membrane and extracellular drug targets. 1618293114 Abstract Frizzled (FZD) receptors mediate Wnt signaling in diverse processes ranging from bone growth to stem cell activity. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. Hannoush ,* 1Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA *Correspondence: hannoush. 05. We cover Rami's new role at Versant, the founding story of. , Partner at Apollo Healthcare Ventures, will join the Company as Board observers. This button displays the currently selected search type. Biomarker interview with Rami Hannoush, Ph. D. Supplementary Figures 1–7, Supplementary Tables 1–3 and Supplementary Methods. … | 77 comments on LinkedInRami Hannoush, Ph. -based biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular. hannoush. Founded in 2022 and led by CEO Dr. The Section of Hematology/Oncology, within the Department of Internal Medicine, Max Rady College of Medicine, in affiliation with CancerCare Manitoba (CCMB) as the Department. D. Mubadala Capital Ventures General Partner Sep 2021. Healthcare VC | Life sciences company creation. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. D. Rami Hannoush, Ph. 2 From the Department of Early Discovery Biochemistry, Genentech, South San Francisco, California 94080 hannoush. 19th Ave New York, NY 95822, USA. 1392 Abstract Wnts are secreted palmitoylated glycoproteins that are important in embryonic development and human cancers. Rami Hannoush, Ph. Marianne Mertens: Show More . 10. I had the pleasure to join Rob Faulkner and Soo Romanoff on a. I had the pleasure to join Rob Faulkner and Soo Romanoff on a panel to talk about the #biotech. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 5mo EditedRami Hannoush, Ph. Ethics declarations. Rami Hannoush is the co-founder, interim CEO and president of EpiBiologics. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. J Pharm Sci 2022 07 10;111(7):1896-1910. He brings a unique blend of investment experience and deep drug discovery expertise to our company creation efforts. D. Drug Discov. , San Francisco, California, USA. ’s Post Rami Hannoush, Ph. The American Peptide Society, APS, a nonprofit scientific and educational organization founded in 1990, provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. “We would like to thank Rami Hannoush for his leadership as co-founder and interim CEO and look forward to an exciting next stage of growth for EpiBiologics under Ann’s leadership. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. This paper describes a multi-parametric method for quantitative analysis of cellular beta-catenin protein levels in a rapid and high-throughput manner. President’s Welcome. D. D. Back. D. Conference Description. Rami Hannoush has been working as a Chief Executive Officer & Co-Founder & Member Board of Directors at EpiBiologics for 8 months. 5 From the Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden, the Faculty of Science, Institute of Experimental Biology, Masaryk. Supplementary Figure 3 S6Taught/moderated by Ryan Watts, founder/CEO of Denali Therapeutics, and Rami Hannoush, former senior scientist at Genentech and now a partner at Mubadala, who bring in former / current colleagues to introduce each of the major functions (e. However, the specificity of the interaction between mammalian WNT and FZD proteins and the subsequent signaling cascade downstream. Synthetic therapeutic peptides: science and market. 20559317. , South San Francisco, California, USA. ”Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Materials availability This study did not generate new unique reagents. Mr. ’s Post Rami Hannoush, Ph. 1021/ja903745s. … | 79 comments on LinkedInCongratulations to our own Rami Hannoush, Principal Scientist, Early Discovery Biochemistry, for being one of ten to receive the U. "To our knowledge, no one has identified ligands that bind to the zymogen," said senior author Rami Hannoush, Genentech, South San Francisco, California. ACS Chemical Biology editors highlight articles from Volume 4, Issue 7, and speak with authors Rami Hannoush and Domagoj Vucic. Taipale, P. com. Funds will also. The author has an hindex of 28, co-authored 68 publications receiving 2989 citations. EpiBiologics Co-Founder. Rami Hannoush, Ph. D. Rami N. Connect Show more profiles Show fewer profiles Explore collaborative articles We’re. Phone and address: 35 28Th Ave #300, San Mateo, CA 94403. Marianne Mertens, [email protected]. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 1y. H. Expand search. Xinxin Gao 1and Rami N. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. D. When expanded it provides a list of search options that will switch the search inputs to match the. D. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. 1038/nprot. Symposium Sponsors. Journal of the American Chemical Society 2009, 131 (26) , 9172-9173. Rami Hannoush, Ph. Citizen and Immigration Services 2019 Outstanding Americans by. D. Rami Hannoush Manage my profile. ’s Post Rami Hannoush, Ph.